M14-327
ClinicalTrials.gov NCT02782663
Research payments
$740,206
Through program year 2020, $740,206 in research payments was reported against M14-327, across 358 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02782663
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $325,941 | 170 |
| 2019 | Research | $414,265 | 188 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Hans Herfarth Chapel Hill, NC Named on 27 payments
- Gerald Dryden Louisville, KY Named on 27 payments
- Edward Loftus Rochester, MN Named on 27 payments
- Alexandra Gutierrez Saint Louis, MO Named on 25 payments
- Lev Ginzburg Great Neck, NY Named on 16 payments
- Marcus Muehlbauer Gainesville, FL Named on 16 payments
- Ellen Scherl New York, NY Named on 15 payments
- John Garber Boston, MA Named on 13 payments
- William Sandborn San Diego, CA Named on 13 payments
- Michael Epstein Annapolis, MD Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.